open access

Vol 75, No 2 (2024)
Original paper
Submitted: 2024-02-10
Accepted: 2024-03-14
Published online: 2024-04-22
Get Citation

Human papillomavirus and Epstein-Barr virus infection in benign thyroid lesions

Yingying Lu1, Runyu Zhao2, Yi Zhang3, Shuixian Huang3, Xiaoping Chen3
·
Pubmed: 38646990
·
Endokrynol Pol 2024;75(2):179-182.
Affiliations
  1. School of Medicine, Shanghai University, Shanghai, China
  2. Postgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, China
  3. Department of Otolaryngology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China

open access

Vol 75, No 2 (2024)
Original Paper
Submitted: 2024-02-10
Accepted: 2024-03-14
Published online: 2024-04-22

Abstract

Introduction: The objective was to investigate the correlation between Epstein-Barr virus (EBV) and human papillomavirus (HPV) infection in the development of benign thyroid lesions.

Material and methods: 29 cases of Hashimoto’s thyroiditis (HT), 133 cases of thyroid adenoma, and 34 cases of HT with thyroid adenoma paraffin embedded tissue samples were used for EBV and HPV quantitative detection.

Results: None of the tissue samples carried HPV DNA. In HT tissue samples, the positive rate of EBV was 55.2% (16/29). In thyroid adenoma tissue samples, the positive rate was 37.6% (50/133). In HT combined with thyroid adenoma tissue samples, the positive rate of EBV was 67.6% (23/34). There was no correlation between EBV infection and clinical features such as age and gender.

Conclusion: The occurrence and development of benign thyroid lesions are closely related to EBV infection. HT combined with thyroid adenoma may be more susceptible to EBV infection than simple HT and thyroid adenoma, which provides a new idea for the diagnosis and treatment of benign thyroid lesions.

Abstract

Introduction: The objective was to investigate the correlation between Epstein-Barr virus (EBV) and human papillomavirus (HPV) infection in the development of benign thyroid lesions.

Material and methods: 29 cases of Hashimoto’s thyroiditis (HT), 133 cases of thyroid adenoma, and 34 cases of HT with thyroid adenoma paraffin embedded tissue samples were used for EBV and HPV quantitative detection.

Results: None of the tissue samples carried HPV DNA. In HT tissue samples, the positive rate of EBV was 55.2% (16/29). In thyroid adenoma tissue samples, the positive rate was 37.6% (50/133). In HT combined with thyroid adenoma tissue samples, the positive rate of EBV was 67.6% (23/34). There was no correlation between EBV infection and clinical features such as age and gender.

Conclusion: The occurrence and development of benign thyroid lesions are closely related to EBV infection. HT combined with thyroid adenoma may be more susceptible to EBV infection than simple HT and thyroid adenoma, which provides a new idea for the diagnosis and treatment of benign thyroid lesions.

Get Citation

Keywords

Hashimoto’s thyroiditis; thyroid adenoma; EB virus; human papilloma virus

About this article
Title

Human papillomavirus and Epstein-Barr virus infection in benign thyroid lesions

Journal

Endokrynologia Polska

Issue

Vol 75, No 2 (2024)

Article type

Original paper

Pages

179-182

Published online

2024-04-22

Page views

117

Article views/downloads

56

DOI

10.5603/ep.99339

Pubmed

38646990

Bibliographic record

Endokrynol Pol 2024;75(2):179-182.

Keywords

Hashimoto’s thyroiditis
thyroid adenoma
EB virus
human papilloma virus

Authors

Yingying Lu
Runyu Zhao
Yi Zhang
Shuixian Huang
Xiaoping Chen

References (16)
  1. Sawicka-Gutaj N, Ruchala M, Feldt-Rasmussen U, et al. Patients with Benign Thyroid Diseases Experience an Impaired Sex Life. Thyroid. 2018; 28(10): 1261–1269.
  2. Weetman AP, Ajjan RA, Weetman AP. The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding. Horm Metab Res. 2015; 47(10): 702–710.
  3. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016; 388(10047): 906–918.
  4. Qiu K, Li K, Zeng T, et al. Integrative Analyses of Genes Associated with Hashimoto's Thyroiditis. J Immunol Res. 2021; 2021: 8263829.
  5. Stojsavljević A, Rovčanin B, Jagodić J, et al. Alteration of Trace Elements in Multinodular Goiter, Thyroid Adenoma, and Thyroid Cancer. Biol Trace Elem Res. 2021; 199(11): 4055–4065.
  6. Haddy N, El-Fayech C, Guibout C, et al. Thyroid adenomas after solid cancer in childhood. Int J Radiat Oncol Biol Phys. 2012; 84(2): e209–e215.
  7. Cracolici V, Ritterhouse LL, Segal JP, et al. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas. Am J Surg Pathol. 2020; 44(7): 881–892.
  8. Fallahi P, Ferrari SM, Vita R, et al. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders. Rev Endocr Metab Disord. 2016; 17(4): 529–535.
  9. Hviid A, Svanström H, Scheller NM, et al. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med. 2018; 283(2): 154–165.
  10. Teng WQ, Chen XP, Xue XC, et al. Distribution of 37 human papillomavirus types in parotid gland tumor tissues. Oncol Lett. 2014; 7(3): 834–838.
  11. Xue Xc, Chen Xp, Yao Wh, et al. Prevalence of human papillomavirus and Epstein-Barr virus DNA in Chinese children with tonsillar and/or adenoidal hypertrophy. J Med Virol. 2014; 86(6): 963–967.
  12. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000; 343(7): 481–492.
  13. Cunha LL, Soares FA, Vassallo J, et al. The role of tumor-infiltrating lymphocytes in papillary thyroid carcinomas. J Endocrinol Invest. 2011; 34(9): 733.
  14. Nowalk A, Green M. Epstein-Barr Virus. Microbiol Spectr. 2016; 4(3).
  15. Ragusa F, Fallahi P, Elia G, et al. Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019; 33(6): 101367.
  16. Deleu S, Allory Y, Radulescu A, et al. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid. 2000; 10(2): 131–140.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl